Tirzepatide Peptide Canada (Tirzepatide – 10mg)

Tirzepatide Peptide Canada, a synthetic dual GLP-1/GIP receptor agonist peptide studied for metabolic and glucose homeostasis research. 10mg lyophilized powder, 99%+ purity verified by Janoshik Analytical via HPLC and mass spectrometry. CAS 2023788-19-2.

• For laboratory research use only.

• Not for human or veterinary use.

• Not intended for diagnosis, treatment, cure, or prevention of any disease.

• Use only in controlled laboratory settings by qualified personnel following appropriate safety procedures..

Tirzepatide is the compound behind well-known pharmaceutical brands in the dual-agonist space and has been widely discussed in metabolic research communities. It is frequently compared with Semaglutide in research settings exploring GLP-1 agonist efficacy differences. For those researching next-generation multi-agonists, Durham Peptides also carries Retatrutide, a triple agonist.

BENEFITS/Tirzepatide Peptide Canada

• Dual receptor activation — studied for simultaneous GIP and GLP-1 receptor engagement

• Metabolic research — explored for body weight and composition changes in clinical trials

• Glycemic control — linked to improvements in glucose homeostasis models

• Comparative studies — frequently assessed alongside semaglutide in head-to-head research

• Incretin biology — investigated for advancing understanding of dual-agonist pharmacology

WHAT RESEARCHERS LOOK AT

• Dual GIP/GLP-1 receptor binding and activation profiles

• Comparative efficacy vs mono-agonists (semaglutide, liraglutide)

• Dose-dependent metabolic and body composition effects

• Insulin sensitivity and beta-cell function modeling

Pharmacokinetic profiling and half-life analysis

QUICK SPECS

• Form: Lyophilized peptide powder

• Net per vial: 10 mg

• Purity: ≥99% (HPLC verified)

• Identity: MS-verified (per COA)

• Storage: 2–8°C, protect from light and moisture

• Reconstitution: Use bacteriostatic water (sold separately)

IDENTITY BASICS

• Molecular Formula: C₂₂₅H₃₄₈N₄₈O₆₈

• Molecular Weight: 4813.45 g/mol

• CAS: 2023788-19-2

• Classification: Dual GIP/GLP-1 receptor agonist